CervoMed rises on patent news, pares gains after $10M equity sale
CervoMed Inc. shares pulled back Thursday, erasing much of an earlier jump linked to a patent development. The Boston biotech quickly announced a $10 million stock offering, flipping the mood. Investors were left to consider potential IP gains next to the hit from dilution.
